of
death, while those with values of <35% were likely to have favorable outcomes. The model
Mukhtarova, Liliya A.,
Fedorova, Yulia Yu.,
Karunas, Aleksandra S.,
Prokofyeva, Darya S.,
Nurgalieva, Alfia Kh.,
Khusnutdinova, Elza K.,
Zagidullin, Shamil Z. (2023) of disability and
death cases in patients. Objective — The goal of our research was conducting a long
Перспективы эпигенетической иммунотерапии рака почки контрольных точек,
основанное на использовании антител против PD-1 (programmed
death 1), PD-L1 (programmed
in the structure of causes of
death among all cardiovascular diseases, behind myocardial infarction (MI